Physician

Sophia El Hamichi, MD

According to 2025 Medicare claims, Sophia Hamichi, MD (NPI: 1255098562) practices ophthalmology in the Cape Coral-Fort Myers, FL market, with the plurality of this provider's patient population coming from Lee, FL. This provider's primary affiliated billing organization is EYE ASSOCIATES OF MANATEE, LLP (NPI: 1366483851; TIN: 650105559) and primary practice location at 33901-9301. Hamichi is affiliated with the UF HEALTH ACO GAINESVILLE, LLC (ACO ID: A5468), participating under the MSSP model.

Hamichi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 296 traditional Medicare patients, billed 8,121 HCPCS/CPT codes, and received $509,327 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 215 prescription claims across 101 beneficiaries totaling $5,873 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 11 records totaling $417. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$255K$509K2023 Medicare payment: $8,074 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $509,327 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20232957$8,074
20242968,121$509,327

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.9K$5.9K2022 Drug cost: $1,183 (USD; Tot_Drug_Cst)2023 Drug cost: $5,821 (USD; Tot_Drug_Cst)2024 Drug cost: $5,873 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20223761$1,183
202362140$5,821
2024101215$5,873

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye5556$125
67028Injection of drug into eye107218$106
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more220242$101
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5153$71
92134Imaging of retina277392$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate611,787$2,926
Ketorolac TromethamineKetorolac Tromethamine17539$783
MoxifloxacinMoxifloxacin Hcl11157$399
Brimonidine TartrateBrimonidine Tartrate281,505$262
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat161,105$240

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$417Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sophia El Hamichi, MD?

Tedicare shows public-source Medicare data for Sophia El Hamichi, MD (NPI 1255098562), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sophia El Hamichi, MD have ACO affiliation data?

Sophia El Hamichi, MD is shown with ACO affiliation data for UF HEALTH ACO GAINESVILLE, LLC (MSSP, ACO ID A5468).

What billing organization is linked to Sophia El Hamichi, MD?

Sophia El Hamichi, MD is linked to EYE ASSOCIATES OF MANATEE, LLP (billing NPI 1366483851) in the available physician profile data.

Does Sophia El Hamichi, MD have Open Payments data?

Sophia El Hamichi, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.